華鐵應急(603300.SH):擬2億元設立子公司 推進人工智能等新一代信息技術上加大研究和投入
格隆匯4月6日丨華鐵應急(603300.SH)公佈,公司擬2億元設立全資子公司哈雷數科,在融合原有數字化團隊的基礎上,在人工智能等新一代信息技術上加大研究和投入,構建“平台+服務”模式;以數據要素為驅動,大力推進產業智能化,踐行公司用先進理念及工具賦能藍領、賦能行業,推動設備租賃產業互聯網變革。
公司擬強化數字化建設力度並逐步轉向為產業鏈客户提供包括技術賦能、設備運營、供應鏈及設備後服務等相關服務。本次設立子公司浙江哈雷數字科技有限公司,符合公司數字化及平台化發展戰略,有利於全面提升運營效率,促進產業鏈一體化協同發展,提升公司綜合競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.